628 related articles for article (PubMed ID: 19132785)
1. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
2. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
4. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
5. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
8. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
10. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
13. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
15. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
16. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
17. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
18. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
Amezcua-Guerra LM; Springall R; Marquez-Velasco R; Gómez-García L; Vargas A; Bojalil R
Arthritis Res Ther; 2006; 8(5):R144. PubMed ID: 16934155
[TBL] [Abstract][Full Text] [Related]
19. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
Hansen B; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
